Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
George Simeon bought 1,007,407 Adarx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 29, 2026
On Sep 28, 2026, George Simeon (Director, 10% owner) bought 1,007,407 Adarx Pharmaceuticals, Inc. shares at US$17.00 for US$17.1M, leaving 592,593 shares. Filed Sep 29, 2026 (Form 4).
- Bought
- 1,007,407 shares
- Price
- US$17.00
- Value
- US$17.1M
- Holding after
- 592,593 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Conversion | 3,334,938 | 3,334,938 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 1,113,666 | 4,448,604 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 512,897 | 4,961,501 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 1,538,691 | 1,538,691 | Indirect | |
| Sep 28, 2026 | Common Stock | Buy | 414,814 | US$17.00 | 1,953,505 | Indirect |
| Sep 28, 2026 | Common Stock | Conversion | 1,667,468 | 1,667,468 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 169,001 | 1,836,469 | Indirect | |
| Sep 28, 2026 | Common Stock | Buy | 592,593 | US$17.00 | 592,593 | Indirect |
Source
Related
- Adarx Pharmaceuticals, Inc.
- George Simeon
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026